China National Medicines Corporation Ltd.

¥29.29As of Sun 8 Nov 2026, 12:00 UTC
SSE:600511Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 1.01%
Div yield 2.73%
ROE 9.85%
Medical Distribution
Beta (5Y) 0.09
PE TTM 11.16
TSR TTM 1.25%
Mkt cap ¥22.10B
ROIC 12.35%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥31
5.59%
(17.50%)
Hold 5|8|12|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.58
0.57
0.60
0.60
29.49%
14.05%
13.54%
1.73%
Revenue¥B
1.135
1.126
1.184
1.246
8.90%
8.60%
12.15%
16.30%
Peers (US$3.313B)
Cap (US$)
PE
3.666B
39.11x
Capital
TTM
5Y
10Y
Leveragex
1.180
0.101
0.098
EBIT/Intx
1.199
0.604
0.563
Own earn%
47.44
2.96
(19.53)
Sh yield%
8.48
29.58
27.25
Owners
Insiders/Inst%
9.71
23.14
Short interest%
5.37
SBC / revenue%
2.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
24–29
$1 testx
0.2
Incr. ROIC%
15